DR. DRORE EISEN, M.D.
Dermatology at Montgomery Rd, Cincinnati, OH

5407663, Apr 18, 1995

Apr 4, 1994

8/222277

Drore Eisen - Cincinnati OH

A61K 728, A01N 4500

424 49

Patients may effectively be treated for inflammatory conditions of the mouth using aqueous anti-inflammatory steroids in solutions that can be swished and expectorated as a mouthwash. Such therapy would allow direct contact of the medication with the diseased mucous membranes and would contact areas of the oral cavity that would not usually be reached with application of creams, gels, or ointments. Compositions containing antifungal agents in addition to steroids are particularly useful. Swishing for three to five minutes, then expectorating the aqueous anti-inflammatory-containing, results in maintenance of contact of the active agents with the oral cavity surfaces for a longer time than would application of gels containing those agents. The mode of application is simple and is not repugnant to the patient as is the application of creams, gels, or ointments.

6297044, Oct 2, 2001

Apr 23, 1999

9/298219

Drore Eisen - Cincinnati OH
Stephen Frist - Monsey NY
Joel Recht - Monsey NY

Oralscan Laboratories, Inc. - Suffern NY

C12M 126, C12M 134

4352871

A non-lacerational method and system employing an abrasive brush for obtaining a transepithelial sample of an epithelial lesion which may be keratinized is disclosed in which an analytical system including an imaging system is provided to detect precancerous and cancerous cells. The transepithelial non-lacerational brush produces sufficient cells from all three layers of the epithelium so that an analytical system comprising a programmed computer can detect which cells require further examination because of a likely suspicion of said pre-cancerous and cancerous conditions. The method and system can apply to the diagnosis non-cancerous conditions as well.

5310545, May 10, 1994

Jan 15, 1993

8/006287

Drore Eisen - Cincinnati OH

A61K 728, A01N 4500

424 49

Compositions used to treat inflammatory diseases of the mouth contain anti-inflammatory steroids in combination with antifungal drugs in an aqueous medium as a mouthwash. Swishing for three to five minutes, then expectorating the mouthwashes results in maintenance of contact of the active agents with the oral cavity surfaces for a longer time than would application of gels containing those agents. The mode of application is simple and is not repugnant to the patient as is the application of creams, gels, or ointments.

6284482, Sep 4, 2001

Apr 23, 1999

9/298218

Drore Eisen - Cincinnati OH
Stephen Frist - Monsey NY
Joel Recht - Monsey NY

Oralscan Laboratories, Inc. - Suffern NY

G01N 130

435 4052

A sample of an epithelial lesion which may be keratinized is disclosed in which an analytical system including an imaging system is provided to detect precancerous and cancerous cells. A transepithelial non-lacerational brush produces sufficient cells from all three layers of the epithelium so that an analytical system comprising a programmed computer can detect which cells exhibit abnormal keratinization and require further examination because of a likely suspicion of said pre-cancerous and cancerous conditions. The method and system can apply to the diagnosis non-cancerous conditions as well.

2003000, Jan 2, 2003

Apr 18, 2002

10/125218

Christopher Prior - Rosemont PA, US
Drore Eisen - Cincinnati OH, US
Louis Herlands - Cambridge MA, US

A61K031/60, A61K031/415, A61K031/405, A61K031/192

514/165000, 514/406000, 514/420000, 514/570000

The invention is directed to uses of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment and prevention of cellular abnormalities of the female reproductive tract.

2003000, Jan 2, 2003

Apr 17, 2002

10/124893

Christopher Prior - Rosemont PA, US
Drore Eisen - Cincinnati OH, US
Louis Herlands - Cambridge MA, US

A61K031/60, A61K031/415, A61K031/405, A61K031/192

514/165000, 514/406000, 514/420000, 514/570000

The invention is directed to uses of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment and prevention of cellular abnormalities of the lung or bronchial pathway.